Ams selects Extra Horizon's on-site care cloud solution to help fight COVID-19

Ams AG (Swiss Stock Exchange: AMS) today announced that it has selected high-performance cloud infrastructure developed by Extra Horizon to support a range of innovative spectral sensor-based on-site care solutions that leverage the power of digital health devices. As the COVID-19 outbreak continues, rapid and accurate testing is essential to ensure public health and the safety of society. In this particular case, AMS 'spectral sensor solution based on the Extra Horizon cloud architecture enables accurate and efficient on-site care detection, which will be one of the powerful weapons in the world's fight against the pandemic.

An extra weapon to fight COVID-19

In the COVID-19 outbreak, highly accurate and secure rapid testing and the availability of immediate data are all the more important, especially when data is critical to the development and management of lockdown policies. The combination of AMS 'spectral sensors and Extra Horizon's connectivity solutions is paving the way for a range of digital field care tests, including extremely fast and accurate lateral tomography (immunoassay data) tests. In fact, thanks to these technologies, AMS has opened a complete production line for the digital rapid detection of SARS-CoV-2 antibodies. In addition, the reliable functionality of the Extra Horizon global platform ensures wide geographic coverage. This means that these test results can be processed safely, reliably, and in real time (up to millions at a time) and ensure full compliance with local data processing regulations, including the GDPR for sensitive data processing.

Pierre Laboisse, Executive Vice President of Global Sales and Marketing at AMS, said: "Restoring normalcy to society requires fast, reliable, efficient testing and usable results through medical grade cloud solutions that are fast, secure and GDPR-compliant. We chose to partner with Extra Horizon based on their proven expertise in healthcare cloud to deliver best-in-class, GDPR-compliant healthcare cloud solutions. Their expertise in developing bespoke solutions and the use of their extensive knowledge make them the ideal partner for this important task. We hope this solution will shorten complex logistics and clinical processes, simplify large-scale testing, and become an effective weapon against outbreaks."

Driving the digital transformation of IVD technology

Ams has advanced spectral sensor technology and products; Extra Horizon offers a powerful, secure and medically compliant mobile app and cloud connectivity. Combined, the two meet the full needs of third-party in vitro diagnostics (IVD) providers, enabling them to develop digital health solutions more quickly and bring them to market. The simple and objective design of AMS 'optical read modules and their built-in spectral sensors enables the detection of biomarkers with a variety of potential correlations, including lateral chromatography, in field care Settings. This will not only improve the inspection process, but also allow cost-effective mass production.

Lars Grieten, CEO of Extra Horizon, said: "This global collaboration is a powerful demonstration of how digital infrastructure can enable cutting-edge health technology-based sensors to deliver on-site care inspection solutions for both professional medical and home environments. In our digital future, rapid detection will become increasingly important. Now, it is already providing much-needed support for managing the COVID-19 crisis by facilitating rapid decision-making."